Ventricular Network Wins '2017 Sina Medicine Most Followed Media Column' at the Rongyao Annual Awards

On December 29, the top ten awards of the “Rongyao 2017 • Sina Medicine Annual Review Rankings” were grandly announced, following a two-month process of registration screening, online voting, and expert review.

This selection was jointly initiated by Sina Medicine and more than 10 industry media outlets and data agencies, including VCBeat, New Health World, Health界 (Healthjie), Saibailan, Huoshi Chuangzao, Pharmadog Bio360, Siqi Circle, Pharmacy Manager, E-Drug Manager, Chuangjianhui, and Drug Briefing. Over 50 expert judges were specially invited to provide comprehensive scoring, and more than 100,000 valid votes were collected online and offline. The final ranking was determined through a comprehensive evaluation conducted from an authoritative, fair, and objective perspective.

The list encompasses major sectors of the pharmaceutical industry, including manufacturing, commercial distribution, retail, smart healthcare, e-commerce, medical devices, and investment and financing, comprehensively presenting the latest landscape and structure of China’s pharmaceutical industry in 2017. Notably, under the leadership and steadfast commitment of Sun Piaoyang, Hengrui Medicine became the first company in China’s pharmaceutical sector to see its market capitalization surpass RMB 200 billion in 2017, setting a historic high. This achievement has been highly recognized by industry peers and expert reviewers, positioning Hengrui Medicine at the forefront across three major rankings.

Furthermore, statistics show that the Public Welfare and Social Responsibility awards garnered enthusiastic participation and vigorous voting from numerous enterprises, emerging as the two most popular categories. This demonstrates that Chinese pharmaceutical companies, while pursuing corporate development, are increasingly shouldering social responsibility, engaging in public welfare initiatives, and actively giving back to society, thereby continuously driving change to advance the cause of human health.

By the end of 2017, over one hundred columnists had shared cutting-edge insights with their audience through the Sina Medicine platform, including market observations, policy interpretations, and news updates related to the pharmaceutical industry.

After a year of accumulating submissions and readership, and based on comprehensive online popularity voting results, Sina Medicine has specially nominated and selected the winners for the Annual Outstanding Authors, Annual Most-Watched Media Columns, and Annual Most Influential Corporate Columns. We look forward to joining hands with an increasing number of outstanding columnists in the future to explore new frontiers together and witness the pharmaceutical industry’s entry into an era of sustained strength.

The list of award winners is as follows:

Sun Piaoyang, Chairman of Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Yu Dechao, Chairman of Innovent Biologics (Suzhou) Co., Ltd.

Liu Dianbo, Chairman of the Board and President of Luye Life Science Group

Academician of the Chinese Academy of Engineering, Dai Kerong

Lei Jufang, Chairman of Tibet Cheezheng Tibetan Medicine Co., Ltd.

Sun Piaoyang, Chairman of Jiangsu Hengrui Medicine Co., Ltd.

Xie Zilong, Chairman of Laobaixing Pharmacy Chain Co., Ltd.

Chairman of Xiuzheng Pharmaceutical Group Co., Ltd. Xiu Laigui

Zheng Xiangling, Chairman of Beijing Tide Pharmaceutical Co., Ltd.

Ke Yunfeng, Chairman of Dashenlin Pharmaceutical Group Co., Ltd.

Du Ying, Chairperson of Zai Lab (Shanghai) Co., Ltd.

Ouyang Jingbo, President of Guangxi Wuzhou Zhongheng Group Co., Ltd.

Fu Gang, Chairman of Baiyang Pharmaceutical Group Co., Ltd.

Ruan Hongxian, Chairman of Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd.

Liu Gexin, Chairman of Sichuan Kelun Pharmaceutical Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Guangzhou Pharmaceutical Holdings Ltd.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd.

Tasly Holding Group Co., Ltd.

Beijing Tide Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Lei Yun Shang Pharmaceutical Group Co., Ltd.

Zai Lab (Shanghai) Co., Ltd.

Ascletis BioScience (Hangzhou) Co., Ltd.

CStone Pharmaceuticals (Suzhou) Co., Ltd.

Shanghai Zhangqiang Medical Technology Co., Ltd.

Yantai Mabio International Biopharmaceutical Co., Ltd.

Beijing Tulip Partner Technology Co., Ltd.

I-Mab Biopharma (Shanghai) Co., Ltd.

Guangzhou Benchmark Medical Co., Ltd.

Boya Ji Yin (Beijing) Biotechnology Co., Ltd.

Beijing Tanghu Technology Co., Ltd.

LBX Pharmacy Chain Joint Stock Co., Ltd.

Sinopharm Holding Guoda Drugstore Co., Ltd.

Yifeng Pharmacy Chain Co., Ltd.

Dashenlin Pharmaceutical Group Co., Ltd.

Beijing Tongrentang (Group) Co., Ltd.

Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd.

Liaoning Chengda Fangyuan Pharmaceutical Chain Co., Ltd.

Shuyu Civilian Pharmacy Chain Co., Ltd.

Shenzhen Dongchen Pharmaceutical Holdings Co., Ltd.

Renhe Pharmacy Network (Beijing) Pharmaceutical Technology Co., Ltd.

Pfizer China “County-Level Whole-Course Management of Cardiovascular and Cerebrovascular Diseases for Public Benefit Project”

Janssen Xi’an’s “Fighting Tuberculosis, Walking Together for Love” Public Welfare Campaign

GE Healthcare “Golden Care Pink Action” Breast Cancer Prevention and Control Public Welfare Campaign

Kanghong Pharmaceutical’s “Bright Vision, Bathed in Light” Public Welfare Fund Project

Roche “Children’s Charity Walk” Public Welfare Program

Aier Eye Hospital’s “Healthy Vision, All in Sight” Public Welfare Assistance Campaign for Fundus Diseases

Kangmei Pharmaceutical’s “Green Seedling Initiative”

Meinian Onehealth "Teach a Man to Fish" Program

Mundipharma “Blue Ribbon Care for Cancer Pain Patients” Large-Scale Public Welfare Campaign

Boao Yihe “With You” Community Diabetes Health Management Public Welfare Project

Bayer (China) Co., Ltd.

Shandong Buchang Pharmaceutical Co., Ltd.

China Resources Double-Crane Pharmaceutical Co., Ltd.

Jointown Pharmaceutical Group Co., Ltd.

Guangxi Wuzhou Zhongheng Group Co., Ltd.

Lin Ling

Shandong Fengqing

Efive

Kobe Crosser

Unique Pharmaceutical Insight

Yuko

April Chen_Pharm

Research_Pharmaceutical Professional_Daniel

Reno Island

Village Man's Diary

VCBeat

PR Newswire

PharmaCube Data

New Kangjie

Pharma Observer Network

WuXi AppTec

PharmaDJ

Clarivate

Good Doctor Friend

Alibaba Health